Jaguar Health Inc.

22/11/2024 | Press release | Distributed by Public on 22/11/2024 14:00

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.